Abstract:
Disclosed herein is a method for screening and diagnosis of Anderson-Fabry Disease in a subject based on biomarker expression in patient samples. Also disclosed are computer systems, kits, and software for implementation of the biomarkers.
Abstract:
There is provided a method of detecting in a sample the presence of an anti-M and/or anti-A and/or anti-C/Y antibody, the method comprising contacting the sample with a diagnostic conjugate provided according to the invention, comprising an oligosaccharide which comprises at least two units of 4,6-dideoxy-4-acylamido-α- pyranose and comprising at least one -(1-3)-link between adjacent 4,6-dideoxy-4-acylamido-α-pyranose units, in which the carbon at position 5 in the pyranose is linked to an R group, where R is independently selected from -CH2OH, -H or an alkyl group having at least one C atom, the oligosaccharide being covalently linked to a non-saccharide molecule or to a surface.
Abstract:
This invention provides monoclonal antibodies that recognize hENTl. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENTl expression and/or activity.
Abstract:
Provided in the following specification are precursors or synthons that are useful for the synthesis of various arabinose-based chemical and radiochemical derivatives of nitroimidazole-containing azomycin arabinosides, such as radioiodinated l-a-D-( 5-deoxy-5-[I*]- iodoarabinofuranosyl)-2-nitroimidazole (*IAZA), and radiofluorinated l-a-D-( 5-deoxy-5-[18F]-iodoarabinofuranosyl)-2-nitroimidazole ( 18FAZA). Such compounds are useful in imaging, therapy, or radiotherapy. Further, various syntheses of said precursors/synthons and the incorporation of said precursors/synthons into kits is provided. The precursors/ synthons provided herein allow for an improved and facile manufacturing process for nitroimidazole-containing azomycin arabinosides.
Abstract:
The physiological regulation of intake, growth and energy partitioning in animals is under the control of multiple genes, which may be important candidates for unraveling the genetic variation in economically relevant traits in beef production. The present invention relates to the identification of single nucleotide polymorphisms (SNPs) and their haplotypes, across the bovine genome in genes encoding polypeptides associated with feed efficiency, and their associations with residual feed intake in beef production. The invention further encompasses methods and systems, including network-based processes, to manage the SNP data, haplotype data and other data relating to specific animals and herds of animals, veterinarian care, diagnostic and quality control data and management of livestock which, based on genotyping, have predictable meat quality traits, husbandry conditions, animal welfare, food safety information, audit of existing processes and data from field locations.
Abstract:
The present teachings are directed towards a thermolysis method of producing iron- containing nanoparticles by providing an iron-containing component, a colloid stabilizing component, and an amount of water. The iron-containing component, the colloid stabilizing component, and the amount of water form a mixture, which is then heated to a temperature sufficient to form iron-containing nanoparticles, which are then isolated from the mixture. Another method is also provided which involves a repetitive shell growth method of producing iron-containing nanoparticles by providing a first amount of an iron-containing component and a colloid stabilizing component; the iron-containing component and the colloid stabilizing component are then mixed and heated to a temperature sufficient to form iron-containing nanoparticles. The mixture is allowed to cool to room temperature, and an additional amount of iron-containing component is added to the mixture, which is then reheated to reaction temperature, and the process is repeated until the isolated iron-containing nanoparticles obtain the desired size.
Abstract:
Novel non-data-aided maximum likelihood estimators for the delays and the attenuations in an ultra-wide bandwidth channel are proposed. Numerical results show that these new estimators outperform the previous non-data-aided maximum likelihood channel estimators derived in the literature. Moreover, in some cases, the performances of the new non-data-aided estimators approach those of the data-aided estimators, enabling us to reduce the overhead expense of pilot symbols.
Abstract:
The present invention provides for the treatment for maintaining or improving cardiac function after a cardiac function disturbing event by the use of a cardioprotective amount of dichloroacetate (DCA) and an inotropic drug The invention also provides for pharmaceutical compositions comprising the combination of DCA and inotropic drug, pharmaceutically acceptable carriers and optionally other therapeutic agents Also provided are the dosage protocols for the DCA and inotropic drug combination.
Abstract:
This invention provides nucleic acid and amino acid sequences of fucosyltransferases from Helicobactor pylori. The invention also provides methods to use the fucosyltransferases to synthesize oligosaccharides, glycoproteins, and glycolipids.
Abstract:
The invention generally relates to a method for fractionating plant material into valuable components including beta-glucan. The method uses an organic solvent and water instead of water alone, acidified water and/or aqueous alkali as a solvent for the slurrying of a grain flour. In addition to concentrating beta-glucan, other product fractions produced by the method include starch concentrate, and organic solvent solubles. If enzyme treatments are used, other product fractions include dextrin, protein hydrolysates and organic solvent solubles. The process is particularly effective in concentrating beta-glucans in a state close to its native form from the endosperm of barley and oat grains.